AB 876 amends the Nurse Anesthetists Act (Business and Professions Code) to explicitly authorize nurse anesthetists to perform anesthesia services, to define what those services include, and to make a clinician’s order for anesthesia the authorization for the nurse anesthetist to select, implement, modify, or abort the modality of anesthesia during care. The bill also provides that when a nurse anesthetist selects and administers medications — including controlled substances — pursuant to such an order, that activity does not count as a “prescription” under 21 C.F.R. § 1300.01.
The measure is declaratory: it affirms that these provisions reflect existing law and an advisory opinion and cites California Society of Anesthesiologists v. Brown (2012).
For compliance officers, hospital counsel, and credentialing staff, the statute tightens the statutory language around autonomy within a clinician’s order while leaving certification, education, and facility credentialing mechanisms under the Board of Registered Nursing and hospital medical staffs intact — creating practical questions about how bylaws, privileging, and controlled-substance regulations will be applied in day-to-day practice.
At a Glance
What It Does
The bill adds Definitions to Section 2826 to list preoperative, intraoperative, postoperative care, pain management, medication selection/administration, and emergency/resuscitation as 'anesthesia services.' It adds Sections 2826.5–2826.7 to authorize nurse anesthetists to perform those services, treat a clinician’s order as authorization to choose and change anesthesia modality, and state that medication administration under that order is not a federal 'prescription.'
Who It Affects
Certified registered nurse anesthetists (CRNAs), the Board of Registered Nursing (which sets approval and certification standards), hospitals and ambulatory surgical centers (medical staff committees and bylaws), and clinicians (physicians, dentists, podiatrists) who order anesthesia. Pharmacists, the Board of Pharmacy, and payer/insurer risk units will also face rule interpretation questions around controlled substances.
Why It Matters
The statute reduces ambiguity about what nurse anesthetists may do once a clinician orders 'anesthesia services' and attempts to sidestep a federal 'prescription' label for in‑theatre medication administration — a move with implications for credentialing, controlled‑substance oversight, and malpractice exposure. Practically, it shifts the compliance focus from whether CRNAs may act to how institutions implement oversight, privileging, and documentation.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
AB 876 rewrites the Nurse Anesthetists Act to put the authority of nurse anesthetists on firmer statutory footing. The law now explicitly lists 'anesthesia services' — from pre-op assessment through intraoperative care, post-op management, pain control, emergency airway and resuscitation — as services a certified nurse anesthetist may provide.
Where prior practice often referenced facility bylaws, advisory opinions, and court rulings, this bill brings those functions into the statute’s definitions.
Crucially, the bill treats an order for anesthesia services from a physician, dentist, or podiatrist as legal authorization for the nurse anesthetist to choose which anesthesia modality to use and to change or abort that choice as patient conditions require. That language assigns decisionmaking authority about modality to the nurse anesthetist within the bounds of the clinician’s order, rather than requiring repeated, separate orders for intraoperative adjustments.On medications, AB 876 says that when a nurse anesthetist selects and administers drugs — including controlled substances — under that clinician’s order, the action does not constitute a 'prescription' under the specified federal regulation.
The bill does not create a new medication‑dispensing license or change certification requirements; instead, it clarifies that medication administration in the context of ordered anesthesia care is an authorized practice activity and not a separate prescription act.Finally, the bill leaves intact the Board of Registered Nursing’s role over certification and program approval; it requires the board to consider national certification and accreditation standards and to adopt stricter standards if needed for public safety. The statute also states that the changes are declaratory of existing law and references the 2012 California appellate decision that has guided dispute resolution in this field, signaling the Legislature’s intent to codify what courts and advisory opinions have said in practice.
The Five Things You Need to Know
The bill adds three new sections (2826.5–2826.7) to the Business and Professions Code expressly authorizing nurse anesthetists to perform anesthesia services and defining that term.
Section 2826(c) expands the statutory definition of 'anesthesia services' to include preoperative, intraoperative, postoperative care, pain management, medication selection/administration, and emergency/resuscitation.
Section 2826.6 makes an order from a physician, dentist, or podiatrist the authorization for a nurse anesthetist to select, implement, modify, or abort an anesthesia modality during care for that specific patient.
Section 2826.7 states that selection and administration of medications (including controlled substances) by a nurse anesthetist under a clinician’s order is not a 'prescription' as defined in 21 C.F.R. § 1300.01.
Section 2833.6 is amended to say the article merely declaratively states existing law and advisory opinion, explicitly citing California Society of Anesthesiologists v. Brown (2012).
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Expanded definitions — what counts as 'anesthesia services'
The amendment to Section 2826 breaks down 'anesthesia services' into concrete activities: preoperative, intraoperative, postoperative care, pain management, medication selection and administration, and emergency/critical care/resuscitation. For compliance teams, this is the operational definition that institutions will use to identify which activities fall under the Nurse Anesthetists Act rather than medical practice statutes. It also reiterates the board’s role in approving education programs and considering national accreditation standards, preserving a regulatory path for tightening training requirements if public safety concerns arise.
Statutory authorization for nurse anesthetists
Section 2826.5 contains a single, clear sentence: a nurse anesthetist is authorized to perform anesthesia services. That line converts what has often been treated as a matter of facility policy or advisory opinion into explicit statutory authority. The practical implication is straightforward: credentialing bodies and courts must interpret nurse anesthetist activities against this statutory baseline rather than relying solely on prior advisory opinions.
Clinician’s order as authorization to choose and change modality
This provision makes an individual clinician’s order for anesthesia services the legal authorization for the nurse anesthetist to select and implement the anesthesia modality and to abort or modify it during care. On the ground, that reduces the need for repeated or granular written orders for intraoperative adjustments and allocates real-time decisionmaking about modality to the CRNA operating under the clinician’s initial order. Hospitals will need to interpret how this statutory authorization interacts with medical staff bylaws and supervision policies.
Medication administration not treated as a 'prescription' under federal regs
Section 2826.7 declares that selection and administration of medication by a nurse anesthetist pursuant to a clinician’s order does not constitute a 'prescription' under 21 C.F.R. § 1300.01. That attempts to narrow the applicability of federal prescription definitions to intraoperative and perioperative administration by CRNAs. Institutions, pharmacies, and enforcement agencies will need to reconcile this statutory language with federal controlled substance rules and operational procedures for dispensing and documentation.
Declaratory clause tying the statute to existing law and case law
The amendment to Section 2833.6 frames the whole article as declaratory of existing law and advisory opinions, specifically referencing the California Society of Anesthesiologists v. Brown decision. That signals legislative intent to codify the practice boundaries recognized by courts and advisory opinions rather than to expand or contract scope of practice beyond prior interpretations. Nevertheless, the declaratory framing will not automatically resolve disputes about application, so litigation or administrative appeals could still follow implementation choices by systems or regulators.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Certified registered nurse anesthetists (CRNAs) — The statute gives explicit statutory authorization to perform a defined set of anesthesia services and to make intraoperative modality decisions under a clinician’s order, reducing ambiguity about their operational authority.
- Patients in settings with limited physician anesthesia availability — By clarifying CRNAs’ ability to select and modify modalities under orders, the law can improve access to timely anesthesia care in rural or underserviced facilities.
- Board of Registered Nursing — The bill affirms the board’s role over certification and program approval and allows the board to reference national standards or adopt stricter requirements for public safety.
- Ambulatory surgery centers and hospitals seeking predictable staffing models — Facilities obtain clearer statutory boundaries to structure privileging, supervision, and staffing plans around CRNA practice.
Who Bears the Cost
- Hospital medical staff and credentialing committees — They will need to revise bylaws, privileging criteria, supervision policies, and possibly supervision agreements to align with the statutory authorization and to document delegation and oversight.
- Physicians, dentists, and podiatrists who previously controlled intraoperative modality decisions — They may see a shift in real-time decision authority to CRNAs and will need to adapt supervision practices and informed‑consent processes.
- Compliance and pharmacy operations — Pharmacy departments, controlled‑substance monitoring programs, and compliance units must interpret the 'not a prescription' clause in relation to federal requirements and update dispensing controls, recordkeeping, and audits accordingly.
- Insurers and risk/claims units — Insurers may face new coverage questions and potential shifts in malpractice exposure allocations between CRNAs and ordering clinicians, prompting adjustments to premiums, credentialing requirements, and contract language.
Key Issues
The Core Tension
The central tension is between formalizing CRNA autonomy within a clinician’s order to improve timely, bedside decisionmaking and preserving layered oversight: hospitals, prescribing clinicians, federal controlled‑substances rules, and malpractice standards. The bill solves uncertainty about authority but shifts the hard questions to institutions and regulators about how that authority is documented, monitored, and reconciled with federal law and existing credentialing frameworks.
AB 876 clarifies statutory authority but leaves several implementation questions unresolved. First, the bill treats a clinician’s order as the trigger for CRNA autonomy over modality, but it does not define the content or form of that order.
Hospitals and ambulatory centers must decide whether a verbal or standing order satisfies the statute and how detailed the initial order must be to lawfully permit intraoperative modifications. Second, the 'not a prescription' language targets a federal definition but does not change Drug Enforcement Administration (DEA) or Board of Pharmacy enforcement authority; federal agencies could interpret and apply controlled‑substance regulations differently than state law frames them, producing operational friction.
Third, while the bill preserves the board’s role over certification and program approval, it leaves intact facility-level credentialing and privileging requirements. That means a nurse anesthetist’s statutory authorization may still be curtailed by hospital bylaws, insurance credentialing, or privileging outcomes.
Finally, the declaratory clause referencing prior case law signals legislative intent but does not immunize the statute from new litigation testing the boundaries of 'authorization,' 'order,' and delegated clinical decisionmaking — particularly in adverse outcome cases where standard-of-care disputes arise.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.